Thirty-one immuno-competent patients with PCNSL stratified by BCL2 and MYC rearrangement, and fifty-seven patients with atypical GB (no visible necrosis) grouped according to idh1 mutation status underwent 3.0-T MRI before treatment in this retrospective study. This evidence concerns the gene IDH1 and primary central nervous system lymphoma.